In the April 5 issue of CMAJ, the proportion of patients receiving combination therapy who did not have clear indications such as proteinuria or heart failure was given as 5.4%.1 That percentage should have been 86.4%. CMAJ apologizes for the error.
In the April 5 issue of CMAJ, the proportion of patients receiving combination therapy who did not have clear indications such as proteinuria or heart failure was given as 5.4%.1 That percentage should have been 86.4%. CMAJ apologizes for the error.